As of 2025-07-03, the Fair Value of Kiniksa Pharmaceuticals Ltd (KNSA) is -1.16 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 27.44 USD, the upside of Kiniksa Pharmaceuticals Ltd is -104.23%.
With the market price of 27.44 USD and our fair value calculation, Kiniksa Pharmaceuticals Ltd (KNSA) is not a good investment. Investing in KNSA stocks now will result in a potential loss of 104.23%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -161.38 | -157.92 | 183.36 | 14.08 | -43.19 | -33.01 |
| YoY growth | 0.30% | 2.14% | 216.11% | -92.32% | -406.68% | -56.09% |
| Market Cap (mil) | 2,002.30 |
| P/E | |
| Forward P/E |
| EPS | -0.23 |
| Avg earnings growth rate | -56.09% |
| TTM earnings | -16.95 |